Lidds AB

LIDDS AB (publ), a pharmaceutical company, develops and sells pharmaceutical products for cancer and other diseases in Sweden. It is developing various drugs, such as NZ-2HOF to treat prostate cancer; NZ-DTX to treat breast, prostate, head, neck, stomach, and lung cancer; NZ-DOX for the treatment of solid tumors; NZ-IO, an immunotherapy; NZ-STING for the treatment of immuno-oncology; and NZ-TLR9 for enhancing cancer immunotherapies. Show More...

Website https://www.liddspharma.com
Sector Healthcare
Industry Biotechnology
Last Quote 0.04 SEK
Last Updated 30-05-2025
External Links Yahoo Finance Morningstar Ratios
Interest Coverage

The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia

	2010-12	2011-12	2012-12	2013-12	2014-12	2015-12	2016-12	2017-12	2018-12	2019-12	TTM
Earnings Per Share SEK	-0.19	-0.38	-0.4	-0.39	-0.54	-0.63	-0.38	-0.34	-0.17	-0.98	-0.98
Dividends SEK
Payout Ratio % *
Shares Mil	10.0	9.0	9.0	10.0	13.0	14.0	17.0	19.0	22.0	23.0	24.0
Book Value Per Share * SEK					7.48	6.87	6.5	6.12	7.09	6.54	6.15
Free Cash Flow Per Share * SEK					-0.76	-1.25	-0.64	-1.01	-0.49	-1.43
Return on Assets %	-3.09	-5.17	-5.08	-5.22	-8.05	-7.77	-5.94	-5.3	-2.55	-14.82	-14.82
Financial Leverage (Average)	1.02	1.02	1.05	1.02	1.02	1.03	1.08	1.03	1.03	1.04	1.04
Return on Equity %	-3.15	-5.28	-5.27	-5.41	-8.23	-7.97	-6.25	-5.56	-2.62	-15.34	-15.34
Return on Invested Capital %	-3.15	-5.28	-5.43	-5.54	-8.18	-8.0	-6.25	-5.56	-2.72	-15.34	-15.34
Interest Coverage					-61.45
Current Ratio	9.35	10.02	2.83	5.7	8.16	6.31	2.45	4.64	5.68	1.57	1.57
Quick Ratio	6.27	7.18	2.83	5.7	8.16	6.31	2.45	4.64	5.68	1.52	1.52
Debt/Equity

Lidds AB

Interest Coverage